Emerging complexities of APOBEC3G action on immunity and viral fitness during HIV infection and treatment
Retrovirology, 05/01/2012Monajemi M et al.
Here, the authors present an overview of recent data that bring to light historical overestimation of A3G's standing as a strictly anti–viral agent. They discuss the limitations of experimental systems used to assess its activities as well as caveats in data interpretation.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.